Provided by Tiger Trade Technology Pte. Ltd.

Lixte Biotechnology Holdings Inc.

5.88
-0.0300-0.51%
Post-market: 5.880.00000.00%17:34 EDT
Volume:140.91K
Turnover:796.30K
Market Cap:72.81M
PE:-5.11
High:6.05
Open:5.93
Low:5.30
Close:5.91
52wk High:6.26
52wk Low:0.6400
Shares:12.38M
Float Shares:11.87M
Volume Ratio:1.26
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1500
EPS(LYR):-1.2600
ROE:-140.99%
ROA:-64.50%
PB:9.16
PE(LYR):-4.67

Loading ...

Aug 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 09, 2021

Major Issues Report

8-K - Current report
Jun 03, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Major Issues Report

8-K - Current report
May 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 21, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 13, 2021

Major Issues Report

8-K - Current report
Mar 26, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 22, 2021

Major Issues Report

8-K - Current report
Dec 17, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 17, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 17, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 17, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 02, 2020

Major Issues Report

8-K - Current report
Nov 27, 2020

Major Issues Report

8-K - Current report
Nov 19, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 19, 2020

Correspondence

CORRESP [Cover] - Correspondence